Buenos Aires English news | Buenos Aires, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

The Russian Direct Investment Fund (RDIF) on Wednesday announced the data from Paraguay regarding the one-shot Russian Sputnik Light vaccine demonstrating high safety profile and a 93.5 per cent efficacy.An official release stated that the one-shot Sputnik Light vaccine has proven to be highly effective against COVID among more than 320,000 subjects who had received the vaccine based on the data collected by July 30, 2021.The data also indicates a high safety profile of Sputnik Light with no serious adverse events associated with vaccination; no deaths related to the vaccination; no cerebral vein thrombosis (CVT) cases after vaccination; no Guillain-Barre syndrome (GBS) cases after vaccination; no capillary leak syndrome cases after vaccination; and no cases of myocarditis or pericarditis reported.The statement said, thanks to its safety and efficacy, the single-component Sputnik Light vaccine is now both used on standalone basis and also studied in combination with vaccines from other producers in a number of countries.The heterogeneous boosting approach ("vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world's first registered vaccine against coronavirus. With this approach proving successful in creating a longer and more durable immunity against the coronavirus, RDIF took the lead in initiating partnerships with other vaccine producers to conduct joint studies of a combination of the first component of Sputnik V with foreign vaccines.In particular, the initial safety results of the world's first study of a combination between Sputnik Light and the AstraZeneca vaccine in Azerbaijan demonstrates a high safety profile for the combined use of the vaccines with no serious adverse events or cases of coronavirus after vaccination.Also RDIF, Ministry of Health of Argentina, Ministry of Science of Argentina and CONICET are conducting a study for the evaluation of the immune response and safety of heterogeneous regimens combining Sputnik Light and vaccines produced by AstraZeneca, Sinopharm and Moderna in the city and province of Buenos Aires, as well as San Luis, Cordoba and La Rioja provinces. The results of the study will be published in a peer-reviewed medical journal.Kirill Dmitriev, CEO of the Russian Direct Investment Fund said: "The one-shot Sputnik Light vaccine enables authorities of Paraguay to speed up the vaccination of the population and accelerate the creation of herd immunity. As demonstrated by data from the Ministry of Health of Paraguay, as well as and a number of other countries around the world, Sputnik Light has a high safety profile and one of the best efficacy numbers as compared to many two-shot vaccines."( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Buenos AiresFOLLOW

Buenos aires, Latest News

Buenos Aires, Sep 28 Lionel Messi will spearhead Argentina's squad for the next triple-header of South American World ... ...

The Russian Direct Investment Fund (RDIF) on Friday announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA). ...

Buenos Aires, Sep 21 Argentine President Alberto Fernandez has reshuffled his cabinet and swore in new Ministers during ... ...

The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced the publication of a study in EClinicalMedicine (an open access peer-reviewed clinical journal published by The Lancet, one of the world's most respected medical ...

Buenos Aires, Sep 13 Argentine President Alberto Fernandez has stressed on the importance of voting in the Primary, ... ...

Buenos Aires, Sep 10 Lionel Messi scored a brilliant hat-trick as Argentina cruised to a 3-0 home win ... ...

The Philippines' Food and Drug Administration approved the single-component Sputnik Light coronavirus vaccine under the emergency use authorization procedure on Monday, the Russian Direct Investment Fund said. ...

The Russian Direct Investment Fund (RDIF) on Wednesday announced the data from Paraguay regarding the one-shot Russian Sputnik Light vaccine demonstrating high safety profile and a 93.5 per cent efficacy. ...